Glenn F. Pierce

Glenn F.
Pierce's current job(s) include being the Director at the World Federation of Hemophilia since 2015, an Independent Director at Voyager Therapeutics, Inc. since 2017, and the Chief Medical Officer & Senior Vice President at Bioverativ Therapeutics, Inc. since 2009.
He is also a Member of the American Society of Hematology, The International Society On Thrombosis & Haemostasis, and the Hemostasis & Thrombosis Research Society.
Dr. Pierce's former job(s) include being an Independent Director at Global Blood Therapeutics, Inc. from 2016 to 2022.
He was also a Principal at Amgen, Inc., Vice President-Research & Clinical Development at Avigen, Inc., Chief Medical Officer & SVP-Global Medical Affairs at Biogen, Inc. from 2009 to 2014, Vice President-Applied Research Hematology at Bayer Healthcare LLC, Vice President-PreClinical Development at Prizm Pharmaceuticals, Inc. from 1994 to 1998, and Vice President-Therapeutic Product Development at Selective Genetics, Inc. from 1998 to 2002.
He also served as the President of the National Hemophilia Foundation and was the Chief Medical Officer at Ambys Medicines, Inc. from 2018 to 2020.
Dr. Pierce's education includes a graduate degree from Washington University in St. Louis and undergraduate and doctorate degrees from Case Western Reserve University.